FHH:CA:TSX-First Trust AlphaDEX US Health Care (CAD)

ETF | Sector Equity |

Last Closing

CAD 41.12

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The First Trust ETF seeks to replicate, to the extent possible, the performance of the StrataQuant® Health Care Index (Index), net of expenses. The investment strategy of the First Trust ETF is to invest in and hold the Constituent Securities of the applicable Index in the same proportion as they are reflected in the Index or securities intended to replicate the performance of such Index. The Index results from applying the AlphaDEX" methodology to the Russell 1000® Index, a market index representing the large capitalization segment of the U.S. equity universe, and then selecting the Constituent Securities for the Index from those qualifying stocks included in the Health Care Sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing FHH:CA

FSR:CA 0.00 % 1.10 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.38% 51% F 51% F
Dividend Return 0.24% 14% F 2% F
Total Return 11.62% 37% F 42% F
Trailing 12 Months  
Capital Gain 17.69% 54% F 56% F
Dividend Return 0.34% 16% F 2% F
Total Return 18.03% 49% F 46% F
Trailing 5 Years  
Capital Gain 39.20% 49% F 67% D+
Dividend Return 8.82% 44% F 17% F
Total Return 48.02% 43% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.50% 37% F 54% F
Dividend Return 5.52% 31% F 50% F
Total Return 0.01% 9% A- 5% F
Risk Return Profile  
Volatility (Standard Deviation) 12.16% 71% C- 65% D
Risk Adjusted Return 45.37% 40% F 61% D-
Market Capitalization 0.01B 9% A- 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.